Clinical Microbiologist
About the project:
The Fleming Fund aims to respond to the global threat of drug-resistant infections, also known as antimicrobial resistance (AMR). The aim of the Fleming Fund’s program of country, regional and fellowship grants, managed by Mott MacDonald, is to improve the ability of Fleming Fund countries to diagnose drug resistant bacteria, and generate data and strengthen surveillance to inform policy and practice at national and international levels.
During Phase I, support has been provided to >200 surveillance sites in Africa and Asia. About two-thirds of these have been in the human health sector with the remainder being in animal health, veterinary services, food safety and environment laboratories. Phase II of the Fleming Fund is set to provide further support to Fleming Fund countries. Investing in similar areas, the program focusses on four outcomes:
• Production of quality AMR/U/C and burden data
• Quality analyses of data
• Sharing analyses and data with decision-makers
• Promoting sustainable investment to counter AMR
About the role:
The Advisor will lead the project's strategy to strengthen public and private lab capacities in AMR diagnostics and sample testing, and in AMR data recording and reporting, as well as external quality assurance (EQA), especially at subnational levels. The Advisor will develop and oversee a mentorship strategy and be responsible for strengthening approaches, tools, SOPs and capacities of lab personnel. The Advisor will work closely with Nigerian laboratories and OHSC as well as with the project director and other senior technical staff. The Advisor will work primarily with human health labs but also with animal health labs.
QUALIFICATIONS
A postgraduate degree in microbiology; laboratory systems, or another related subject; PhD and/or MD preferred.
A minimum of 7 years of professional experience working in public health in Nigeria.
Extensive experience working with OH/AMR surveillance and labs in Nigeria.
Demonstrated knowledge of WHO AMR systems and practice standards.
Excellent interpersonal, writing, and English language skills.
MSH is an equal opportunity employer and will not discriminate against any employee or applicant for employment on the basis of race, color, sex, sexual orientation, gender or gender identity, religion, creed, citizenship, national origin, age, veteran status, or disability unrelated to job requirements. MSH will take affirmative action to ensure that qualified applicants are employed and that employees are treated without regard to their race, age, color, religion, sex, sexual orientation, gender identity, national origin, veteran and disability status. In compliance with U.S. Department of Labor Executive Order 11246, Section 503 of the Rehabilitation Act, and Section 4212 of the Vietnam Era Readjustment Assistance Act, MSH has developed and maintains an affirmative action program and plan.
EEO is the Law – English
EEO is the Law – Spanish
Pay Transparency Nondiscrimination Poster
MSH EEO-AA Policy
The Fleming Fund aims to respond to the global threat of drug-resistant infections, also known as antimicrobial resistance (AMR). The aim of the Fleming Fund’s program of country, regional and fellowship grants, managed by Mott MacDonald, is to improve the ability of Fleming Fund countries to diagnose drug resistant bacteria, and generate data and strengthen surveillance to inform policy and practice at national and international levels.
During Phase I, support has been provided to >200 surveillance sites in Africa and Asia. About two-thirds of these have been in the human health sector with the remainder being in animal health, veterinary services, food safety and environment laboratories. Phase II of the Fleming Fund is set to provide further support to Fleming Fund countries. Investing in similar areas, the program focusses on four outcomes:
• Production of quality AMR/U/C and burden data
• Quality analyses of data
• Sharing analyses and data with decision-makers
• Promoting sustainable investment to counter AMR
About the role:
The Advisor will lead the project's strategy to strengthen public and private lab capacities in AMR diagnostics and sample testing, and in AMR data recording and reporting, as well as external quality assurance (EQA), especially at subnational levels. The Advisor will develop and oversee a mentorship strategy and be responsible for strengthening approaches, tools, SOPs and capacities of lab personnel. The Advisor will work closely with Nigerian laboratories and OHSC as well as with the project director and other senior technical staff. The Advisor will work primarily with human health labs but also with animal health labs.
QUALIFICATIONS
A postgraduate degree in microbiology; laboratory systems, or another related subject; PhD and/or MD preferred.
A minimum of 7 years of professional experience working in public health in Nigeria.
Extensive experience working with OH/AMR surveillance and labs in Nigeria.
Demonstrated knowledge of WHO AMR systems and practice standards.
Excellent interpersonal, writing, and English language skills.
MSH is an equal opportunity employer and will not discriminate against any employee or applicant for employment on the basis of race, color, sex, sexual orientation, gender or gender identity, religion, creed, citizenship, national origin, age, veteran status, or disability unrelated to job requirements. MSH will take affirmative action to ensure that qualified applicants are employed and that employees are treated without regard to their race, age, color, religion, sex, sexual orientation, gender identity, national origin, veteran and disability status. In compliance with U.S. Department of Labor Executive Order 11246, Section 503 of the Rehabilitation Act, and Section 4212 of the Vietnam Era Readjustment Assistance Act, MSH has developed and maintains an affirmative action program and plan.
EEO is the Law – English
EEO is the Law – Spanish
Pay Transparency Nondiscrimination Poster
MSH EEO-AA Policy